IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
The gene encoding the Insulin-like Growth Factor 2 mRNA binding protein 2/IMP2 is amplified and overexpressed in many human cancers, accompanied by a poorer prognosis. Mice lacking IMP2 exhibit a longer lifespan and a reduced tumor burden at old age. Herein we show in a diverse array of human cancer...
Autori principali: | Dai, N, Ji, F, Wright, J, Minichiello, L, Sadreyev, R, Avruch, J |
---|---|
Natura: | Journal article |
Pubblicazione: |
eLife Sciences
2017
|
Documenti analoghi
Documenti analoghi
-
IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
di: Dai, N, et al.
Pubblicazione: (2017) -
mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
di: Dai, Ning, et al.
Pubblicazione: (2014) -
Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation
di: Regué, L, et al.
Pubblicazione: (2019) -
An adipose lncRAP2-Igf2bp2 complex enhances adipogenesis and energy expenditure by stabilizing target mRNAs
di: Alvarez-Dominguez, Juan R, et al.
Pubblicazione: (2022) -
mRNA quality control: an ancient machinery recognizes and degrades mRNAs with nonsense codons.
di: Behm-Ansmant, I, et al.
Pubblicazione: (2007)